Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY

Source
Find a Tender
Type
Contract (Supply)
Duration
4 year (est.)
Value
£1
Sector
HEALTH
Published
29 Aug 2025
Delivery
01 Oct 2025 to 30 Sep 2029 (est.)
Deadline
n/a

Concepts

Location

UK

Geochart for 2 buyers and 2 suppliers

2 buyers

2 suppliers

Description

Provision of measles, mumps, rubella and varicella (MMRV) vaccine (2025)

Total Quantity or Scope

Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.The awarding of lots is not appropriate for this procurement.

Award Detail

1 Merck Sharp & Dohme (London)
  • Num offers: 2
  • Value: £1
2 Glaxosmithkline (London)
  • Num offers: 2
  • Value: £1

Renewal Options

This contract has the option to be extended for a period or periods up to an additional 24 months.

Award Criteria

Comparison with specification _
Risk to programme delivery _
Shelf life _
Social value _
Benchmark price _
Offer price _
Additional costs _
Additional savings _
Storage cost _

CPV Codes

  • 33651600 - Vaccines

Indicators

  • Options are available.

Other Information

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier. The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.

Reference

Domains